GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » DarioHealth Corp (NAS:DRIO) » Definitions » Cyclically Adjusted PS Ratio

DarioHealth (DarioHealth) Cyclically Adjusted PS Ratio : 0.21 (As of Jun. 09, 2024)


View and export this data going back to 2013. Start your Free Trial

What is DarioHealth Cyclically Adjusted PS Ratio?

As of today (2024-06-09), DarioHealth's current share price is $1.31. DarioHealth's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was $6.22. DarioHealth's Cyclically Adjusted PS Ratio for today is 0.21.

The historical rank and industry rank for DarioHealth's Cyclically Adjusted PS Ratio or its related term are showing as below:

DRIO' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.17   Med: 0.6   Max: 1.85
Current: 0.21

During the past years, DarioHealth's highest Cyclically Adjusted PS Ratio was 1.85. The lowest was 0.17. And the median was 0.60.

DRIO's Cyclically Adjusted PS Ratio is ranked better than
87.5% of 344 companies
in the Healthcare Providers & Services industry
Industry Median: 1.19 vs DRIO: 0.21

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

DarioHealth's adjusted revenue per share data for the three months ended in Mar. 2024 was $0.167. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $6.22 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


DarioHealth Cyclically Adjusted PS Ratio Historical Data

The historical data trend for DarioHealth's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DarioHealth Cyclically Adjusted PS Ratio Chart

DarioHealth Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 1.85 0.64 0.27

DarioHealth Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.62 0.61 0.51 0.27 0.25

Competitive Comparison of DarioHealth's Cyclically Adjusted PS Ratio

For the Health Information Services subindustry, DarioHealth's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DarioHealth's Cyclically Adjusted PS Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, DarioHealth's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where DarioHealth's Cyclically Adjusted PS Ratio falls into.



DarioHealth Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

DarioHealth's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=1.31/6.22
=0.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DarioHealth's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, DarioHealth's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.167/131.7762*131.7762
=0.167

Current CPI (Mar. 2024) = 131.7762.

DarioHealth Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.000 100.560 0.000
201409 0.000 100.428 0.000
201412 1.133 99.070 1.507
201503 1.136 99.621 1.503
201506 2.083 100.684 2.726
201509 2.625 100.392 3.446
201512 2.351 99.792 3.105
201603 3.104 100.470 4.071
201606 2.398 101.688 3.108
201609 2.554 101.861 3.304
201612 2.910 101.863 3.765
201703 2.797 102.862 3.583
201706 2.542 103.349 3.241
201709 2.761 104.136 3.494
201712 2.693 104.011 3.412
201803 2.351 105.290 2.942
201806 2.080 106.317 2.578
201809 1.596 106.507 1.975
201812 0.987 105.998 1.227
201903 1.219 107.251 1.498
201906 0.777 108.070 0.947
201909 0.736 108.329 0.895
201912 1.058 108.420 1.286
202003 0.539 108.902 0.652
202006 0.434 108.767 0.526
202009 0.279 109.815 0.335
202012 0.256 109.897 0.307
202103 0.256 111.754 0.302
202106 0.335 114.631 0.385
202109 0.342 115.734 0.389
202112 0.339 117.630 0.380
202203 0.411 121.301 0.446
202206 0.276 125.017 0.291
202209 0.288 125.227 0.303
202212 0.263 125.222 0.277
202303 0.256 127.348 0.265
202306 0.218 128.729 0.223
202309 0.122 129.860 0.124
202312 0.125 129.419 0.127
202403 0.167 131.776 0.167

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


DarioHealth  (NAS:DRIO) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


DarioHealth Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of DarioHealth's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


DarioHealth (DarioHealth) Business Description

Traded in Other Exchanges
N/A
Address
18 W. 18th Street, New York, NY, USA, 10011
DarioHealth Corp is a digital health company. It offers user-centric a multi-chronic condition digital therapeutics platform that delivers personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. DarioHealth serves customers globally.
Executives
Jon H. Kaplan director 1573 MALLORY LANE, SUITE 100, BRENTWOOD TN 37027
Erez Raphael director, officer: Chief Executive Officer 9 HALAMISH STREET, CAESAREA INDUSTRIAL PARK, CAESAREA L3 38900
Dennis M Mcgrath director C/O PAVMED INC., ONE GRAND CENTRAL PLACE, STE. 4600, NEW YORK NY 10165
Dror Bacher officer: Chief Operating Officer 9 HALAMISH STREET, CAESAREA INDUSTRIAL PARK L3 3088900
Oded Cohen officer: GM MSK 8 HATOKHEN ST., CAESAREA INDUSTRIAL PARK L3 3088900
Adam K Stern director STERN AEGIS VENTURES, 810 7TH AVENUE 22ND FLOOR, NEW YORK NY 10019
Dennis Matheis director 8 HATOKHEN ST., CAESAREA L3 38900
Yoav Shaked director 8 HATOKHEN ST., CAESAREA L3 3088900
Yadin Shemmer director 8 HATOKHEN ST., CAESAREA L3 3088900
Richard Allan Anderson officer: President, GM of North America C/O DARIOHEALTH CORP., 18 W. 18TH ST, 5TH FLOOR, NEW YORK NY 10011
Yalon Farhi director C/O LABSTYLE INNOVATIONS CORP., 9 HALAMISH ST., CAESAREA INDUSTRIAL PARK, CAESAREA L3 3088900
Hila Karah director 9 HALAMISH STREET, CAESAREA INDUSTRIAL PARK, CAESAREA L3 38900
Zvi Ben-david officer: Chief Financial Officer 9 HALAMISH STREET, CAESAREA INDUSTRIAL PARK, CAESAREA L3 38900
Glen Moller director 8 HATOKHEN ST., CAESAREA L3 3088900
Olivier Roger Jarry officer: See Remarks 15 ROCKRIDGE RD, LARCHMONT NY 10538-3918